In trading on Wednesday, the ARK Genomic Revolution ETF is outperforming other ETFs, up about 6.1% on the day. Components of that ETF showing particular strength include shares of Pacific Biosciences of California, up about 22.5% and shares of Prime Medicine, up about 19.3% on
Mostramos la idea principal publicamente. Crea una cuenta gratis para seguir leyendo el articulo completo, guardarlo, comentarlo y conectarlo con contexto de mercados y OSINT.